ABC | Volume 111, Nº4, Octuber 2018

Review Article Oliveira et al Risk-benefit of carotid revascularization Arq Bras Cardiol. 2018; 111(4):618-625 9. Eckstein HH, Ringleb P, Allenberg JR, Berger J, Fraedrich G, Hacke W, et al. Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial. Lancet Neurol. 2008;7(10):893-902. 10. Brott TG, Hobson RW, Howard G, Roubin GS, Clark WM, Brooks W, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010;363(1):11-23. 11. Rosenfield K, Matsumura JS, Chaturvedi S, Riles T, Ansel GM, Matzoer DC, et al.et al. Randomized Trial of Stent versus Surgery for Asymptomatic Carotid Stenosis. N Engl J Med. 2016;374(11):1011-20. 12. International Carotid Stenting Study investigators, Ederle J, Dobson J, featherstone RL, Benati LH, van der Worp HB, et al. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial. Lancet. 2010;375(9719):985-97. 13. Paraskevas KI, Kalmykov EL, Naylor AR. Stroke/Death Rates Following Carotid Artery Stenting and Carotid Endarterectomy in Contemporary Administrative Dataset Registries: ASystematic Review. Eur J Vasc Endovasc Surg. 2015;51(1):3-12. 14. Naylor AR. Why is the management of asymptomatic carotid disease so controversial? Surgeon. 2015;13(1):34-43. 15. Abbott AL, Paraskevas KI, Kakkos SK, Golledge J, Eckstein HH, Diaz-Sandoval LJ, et al. Systematic Review of Guidelines for the Management of Asymptomatic and Symptomatic Carotid Stenosis. Stroke.2015;46(11):3288-301. 16. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association. Circulation. 2017;35(10):e146-e603. 17. Halliday A, Harrison M, Hayter E, Kong X, Mansfield A, Marro J, et al. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. Lancet. 2010;376(9746):1074-84. 18. Writing Group Members, Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart Disease and Stroke Statistics-2016 Update a Report from the American Heart Association. Circulation.2016;133(4):447-54. 19. Padua A De, Favarato D. Original article mortality due to cardiovascular diseases in Brazil and in the metropolitan region of São Paulo : A 2011 Update. Arq Bras Cardiol. 2012;2(99):755-61. 20. Rutherford JD, Pfeffer MA, Moye LA, Davis BR, Flaker GC, Kawey PR, et al. Effects of captopril on ischemic events after myocardial infarction: results of the Survival and Ventricular enlargement trial-SAVE Investigators. Circulation. 1994;90:1731-8. 21. Yusuf S, Pepine CJ, Garces C, Pouler H, Salem D, Kostis J, et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet. 1992;340(8829):1173-8. 22. Al-Mallah MH, Tleyjeh IM, Abdel-Latif AA, Weaver WD. Angiotensin- Converting Enzyme Inhibitors in Coronary Artery Disease and Preserved Left Ventricular Systolic Function. A Systematic Review andMeta-Analysis of Randomized Controlled Trials. J AmColl Cardiol. 2006;47(8):1576-83. 23. Montalescot G, Sechtem U, Achenbach S, Achenbach S, Andreotti F, Arden C, et al. et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34(38):2949-3003. 24. Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, et al. 2012 ACCF/AHA Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the AmericanCollege of Cardiology Foundation/AmericanHeart Association Task Force on Practice Guidelines, and the American College of Ph. J AmColl Cardiol. 2012;60(24):e44-e164. 25. Cesar LA, Ferreira JF,ArmaganijanD, Gowdak LH, Mansur AP, Bodanese L,C; Sociedade Brasileira de Cardiologia. Diretriz de doença coronária estável. Arq Bras Cardiol. 2014;103(supl 2):1-59. 26. Cholesterol Treatment Triallists(CTT) Collaboration, Baigent C, Blackwell L, Emberson J, Holland J, Reith C, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170 000 participants in 26 randomised trials. Lancet. 2010;376(9753):1670-81. 27. Park SJ, Kang SJ, Ahn JM, Chang M, Yun SC, Roh JH, et al. Effect of Statin Treatment onModifying Plaque Composition ADouble-Blind, Randomized Study. J Am Coll Cardiol. 2016;67(15):1772-83. 28. Yusuf S, Bosch J, Dagenais G, Zhu J, Xavier D, Liu L, et al. Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease. N Engl J Med. 2016;374(21):2012-31. 29. Brott TG, Halperin JL, Abbara S, Bacharach JM, Barr JD, Bush RL, et al. Guideline on the management of patients with extracranial carotid and vertebral artery disease. Vasc Med. 2011;16(1):35-77. 30. KernanWN, Ovbiagele B, BlackHR, BravataDM, ChimowitzMI, Ezekowitz MD, et al. Guidelines for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals from the AmericanHeart Association/American Stroke Association. Stroke. 2014;45(7):2160-236. 31. AboyansV,Ricco J-B,BartelinkM-L,BjorckM,BrodmannM,CohnertT,etal. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018; 39(9):763-816. 32. Gurm HS, Yadav JS, Fayad P, Katzen BT, Mishkel GJ, Bajwa TK, et al. Long- term results of carotid stenting versus endarterectomy in high-risk patients. N Engl J Med. 2008;358(15):1572-9. 33. Howard G, Roubin GS, Jansen O, Hendrikse J, Halliday A, Froecrich G, et al. Association between age and risk of stroke or death from carotid endarterectomy and carotid stenting: Ameta-analysis of pooled patient data from four randomised trials. Lancet. 2016;387(10025):1305-11. 34. Bonati LH, Lyrer P, Ederle J, Featherstone R, Brown MM. Percutaneous transluminal balloon angioplasty and stenting for carotid artery stenosis. Cochrane Database Syst Rev. 2012;12(9):CD000515. 35. Voeks JH, Howard G, Roubin GS,Malas MB, Cohen DJ, Sternbergh WC, et al. Age and outcomes after carotid stenting and endarterectomy: The Carotid Revascularization Endarterectomy Versus Stenting Trial. Stroke . 2011. 42(12):B484-90. 36. Gray WA, Rosenfield KA, Jaff MR, Chaturvedi S, Peng L, Verta P, et al. Influence of site and operator characteristics on carotid artery stent outcomes: analysis of the CAPTURE 2 (Carotid ACCULINK/ACCUNET Post Approval Trial toUncover Rare Events) clinical study. JACCCardiovasc Interv. 2011;4(2):235-46. 37. Nallamothu BK, Gurm HS, Ting HH, Goodney PP, Rogers MA, Curtis JP, et al. Operator experience and carotid stenting outcomes in Medicare beneficiaries. JAMA. 2011;306(12):1338-43. 38. Fiehler J, JansenO,Berger J,EcksteinH-H,RinglebPA,StingeleR.Differences in complication rates among the centres in the SPACE study. Neuroradiology. 2008;50(12):1049-53. 39. Calvet D, Mas JL, Algra A, Becquemin JP, Bonati LH, Dobson J, et al. Carotid stenting is there an operator effect? A pooled analysis from the carotid stenting trialists’ collaboration. Stroke. 2014;45(2):527-32. 40. Lin PH, Bush RL, Peden EK, ZhouW, Guerrero M, Henao EA, et al. Carotid artery stenting with neuroprotection: assessing the learning curve and treatment outcome. Am J Surg . 2005;190(6):850-7. 41. RerkasemK, Rothwell PM. Carotid endarterectomy for symptomatic carotid stenosis. Cochrane Database Syst Rev. 2011;(4):CD001081. 624